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Abstract
Surface enhanced Raman spectroscopy (SERS) holds great promise in bio-
sensing because of its single-molecule, label-free sensitivity. We describe here
the use of a graphene–gold hybrid plasmonic platform that enables quantita-
tive SERS measurement. Quantification is enabled by normalizing analyte
peak intensities to that of the graphene G peak. We show that two complemen-
tary quantification modes are intrinsic features of the platform and that
through their combined use, the platform enables accurate determination of
analyte concentration over a concentration range spanning seven orders of
magnitude. We demonstrate, using a biologically relevant test analyte, the
amyloid β-protein (Aβ), a seminal pathologic agent of Alzheimer's disease, that
linear relationships exist between (a) peak intensity and concentration at a
single plasmonic hot spot smaller than 100 nm and (b) frequency of hot spots
with observable protein signals, that is, the colocation of an Aβ protein and a
hot spot. We demonstrate the detection of Aβ at a concentration as low as
10−18 M after a single 20 μl aliquot of the analyte onto the hybrid platform.
This detection sensitivity can be improved further through multiple applica-
tions of analyte to the platform and by rastering the laser beam with smaller
step sizes.
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1 | INTRODUCTION
The development of sensitive techniques for the detection
and quantitative analysis of biomolecules[1–4] is impor-
tant for trace element detection, environmental monitor-
ing, and early stage diagnosis and treatment of diseases.
Detection methods include high-performance liquid
chromatography,[5] liquid chromatography mass
spectrometry,[6] and enzyme-linked immunosorbent
assays.[7] A limit of detection of 1 ng/ml has been
achieved with these platforms, a sensitivity that is among
the best currently achievable in biological sensing.
Surface-enhanced Raman scattering (SERS) is a method
that has gained increasing notice because of its ability to
achieve single molecule detection with high molecular
specificity[8–11] without the use of biological labels.
Recent advances in nanotechnology have led to many
SERS-based analytical applications. For example, self-
assembled monolayer-coated colloidal gold platforms are
able to detect Rhodamine 6G in the concentration range
of 0.1–5 μM.[7] Metallic glassy nanowire arrays have a
dynamic range of 1–10 nM for Rhodamine B.[12] Gold
nanoparticles allow detection of glucose in the concentra-
tion range of 0.5–32 mM.[13]
Accurate analyte quantification using SERS has been
challenging due primarily to the lack of a built-in marker
of local electromagnetic (EM) field intensity, which is
known to vary substantially from location to location on
plasmonic surfaces currently in use.[14] Signal intensity
depends on the local EM field intensity as well as analyte
concentration.[15] This means that signal intensities mea-
sured at different points on a surface vary even if analyte
concentration is constant. SERS signal intensity per se
does not have a one-to-one correlation with analyte con-
centration. Such correlation could be established only if
the EM field intensity at an individual plasmonic hot spot
could be determined independent of analyte concentra-
tion. Prior studies have employed the assembly of marker
molecules as internal standards.[13] However, the non-
planar topology typical of plasmonic surfaces, which can
create local inhomogeneities in marker concentration
significantly confounds the situation. In addition, the
relatively large size of typical SERS internal standards
(~50 nm)[7,16] relative to hot spot size can interfere with
adsorption of the actual analyte at the hot spot, preclud-
ing Raman signal production by the analyte.
We report here the quantification ability of an
ultrasensitive graphene-plasmonic hybrid platform[17]
that largely eliminates these sources of variability. The
platform incorporates a single atomic layer of graphene
overlaying a gold surface consisting an array of
nanopyramids, each of which is ~200 nm in width and
height. Graphene deforms itself to conform to the
substrate geometry via van der Waals forces.[17] The peri-
odicity and size of individual pyramids are chosen for the
optimization of surface plasmon resonance by laser exci-
tation at 785 nm. The novelty of this work is that the
single-layer graphene serves as an internal standard,
which allows for accurate quantitation[9] and also pro-
vides additional Raman signal enhancement. Wang et al.
demonstrated that the addition of a graphene monolayer
on top of gold nanopyramids led to an enhancement of
the Raman signal for small molecules (RG6) and proteins
(lysozyme) and that by locating the areas of highest
graphene peak intensity, they could more easily locate
local hot spots, where the analyte signal also had the
greatest enhancement.[17] SERS enhancement results pri-
marily through an EM mechanism (up to 108 fold or 1014
fold in combination with resonance effects). A chemical
mechanism also contributes to the enhancement due to
the charge transfer between the analyte and
graphene[18,19] and π–π stacking of aromatic molecules
with π-bonds of graphene,[20] but to a much lesser degree
(10- to100-fold).[17]
We use the amyloid β-protein (Aβ), a well-studied
pathologic agent of Alzheimer's disease,[21–23] as an
example biologically relevant analyte to assess the poten-
tial of the hybrid platform for quantification and subse-
quent study of Aβ assembly dynamics. We observe two
complementary quantification modes. The first (high
analyte concentration regime) relates analyte concentra-
tion to the SERS peak intensity at individual SERS hot
spots. The second (low concentration regime) relates ana-
lyte concentration to the probability of observing any
Raman signal at any hot spot. In combination, these two
modes enable analyte detection in a concentration range
spanning seven orders of magnitude (10−18 to 10−15 M,
10−13 to 10−11 M).
2 | MATERIALS AND METHODS
2.1 | Chemicals and reagents
Unless specified otherwise, all chemicals and reagents
were obtained from Sigma-Aldrich (St. Louis, MO) and
were of the highest purity available.
2.2 | Substrate fabrication
The graphene–gold hybrid platform fabrication is based
on sphere lithography, as previously reported.[24] The
periodic gold nanopyramid structure with tunable size
and sharpness is fabricated by a wafer-scale bottom-up
templating technology. Spin-coated on (001) silicon
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wafers, close-packed monolayer polystyrene balls with a
diameter of 200 nm serve as templates. The pyramids
form a quasiperiodic array of hexagonal arrangement
that is uniformly distributed across the entire sample sur-
face of 1 × 1-cm area. Because of the way the pattern is
generated (self-assembly of polystyrene balls), variations
in the spacing between pyramids, and the sizes of the
pyramids themselves, can vary. This variance has been
estimated to be ±30 nm.[24]
Monolayer graphene is grown by chemical vapor
deposition (CVD) essentially as described.[17] Briefly, a
25-μm thick copper foil (Alfa Aesar cat #13382) is cut
into 5-cm squares. The copper foil is loaded onto the cen-
ter of a quartz CVD chamber, and the furnace is heated
to ≈1025C under the flow of hydrogen gas (~1,000
sccm). After 30-min annealing, the CVD growth was
carried out with 20-torr total pressure with methane gas
(~20 sccm) and hydrogen gas (~1,000 sccm) for 15 min.
The chamber was then cooled to room temperature.
The graphene monolayer is transferred from the Cu
foil onto the gold nanopyramid surface by coating the
graphene-on-Cu surface with polymethyl methacrylate,
dissolving the Cu in iron nitrate, and then lifting the
graphene from the solution with a silicon wafer, followed
by polymethyl methacrylate removal with acetone, two
washes in water, and finally lifting the graphene
monolayer from the surface with the nanopyramid
substrate.[17,25,26] This produces the graphene–gold
nanopyramid hybrid surface with <5% of the graphene
surface displaying holes or cracks.[26] Platforms can be
fabricated with user-determined areas. We typically use
platforms of ~1 cm2.
2.3 | Scanning electron microscopy
Scanning electron microscopic (SEM) analysis was per-
formed using FEI Nova Nano SEM 230 instrument, an
accelerating voltage of 10 kV and a beam current of 0.14
A. After the production of the gold pyramids, as
described above, the substrate was mounted onto an SEM
stub using double-sided adhesive tape. Imaging was per-
formed at magnifications ranging from 30,000 to 200,000.
2.4 | Micro-Raman spectroscopy
A 20-μl volume of Aβ42 was pipetted onto the center of
the platform and then immediately dried in vacuo.
Raman spectra were measured using a Renishaw inVia
microscope under ambient conditions. Excitation was
accomplished using a GaAlAs diode laser of wavelength
785 nm. A laser power of 0.5 mW, a grating of 1,800
lines/mm, and an objective lens of 50× were used. A step
size of 200 nm was used for Raman mapping. Raman
data were analyzed using Renishaw WiRE 4.2 software.
Strong hotpots appear in between pyramids and at their
apices.[17]
2.5 | Synthesis of Aβ
Aβ was synthesized in the UCLA Biopolymer facility and
then purified and characterized, as described
previously.[27] Briefly, peptide synthesis was performed
on an automated peptide synthesizer (model 433A,
Applied Biosystems, Foster City, CA, USA) using
9-fluorenylmethoxycarbonyl-based methods on preloaded
Wang resins. Aβ was purified to >97%, using reverse-
phase high-performance liquid chromatography. Quanti-
tative amino acid analysis and mass spectrometry yielded
the expected composition and molecular weight. Purified
peptides were stored as lyophilizates at −20C.
2.6 | Preparation of Aβ
Aβ was prepared by dissolution in 10% (v/v) 60-mM
NaOH, 45% (v/v) Milli-Q water, and 45% (v/v) 22.2-mM
sodium phosphate, pH 7.4, to yield a nominal Aβ concen-
tration of 1 mg/ml in 10-mM sodium phosphate, pH 7.4.
The Aβ solution was then sonicated for 1 min in a bath
sonicator (Branson Model 1510, Danbury, CT, USA) and
filtered through a prewashed 30,000 molecular weight
cut-off Microcon centrifugal filter device (Millipore,
Billerica, MA, USA) for 15 min at 16,000 × g. The con-
centration of Aβ in the eluate was determined using UV
absorbance (ε280 = 1,280 cm−1 M). The peptide was
diluted with 10-mM sodium phosphate, pH 7.4, to a final
concentration of 20 μM before use. Serial dilutions were
then done in 10-mM sodium phosphate, pH 7.4. All mea-
surements were performed at 22C. This protocol repro-
ducibly yields aggregate-free Aβ monomer in rapid
equilibrium with low order oligomers, which is termed
low molecular weight Aβ.[28]
2.7 | Histograms of signal intensity
The signal intensities observed at 935 cm−1 in samples
analyzed at concentrations of 10−17, 10−15, and 10−13 M
were incorporated into a data table (see text for ratio-
nale), each element of which represented the intensity
from a single hot spot. The total numbers of hot spots at
which signals were observed, ni, were 14 (10
−17 M), 100
(10−15 M), and 200 (10−13 M). To produce a histogram of
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intensities, individual intensities were binned using a bin
size of 100 μAU. Frequencies were calculated according
to the formula fi = ni/nt × 100; in which fi is percent fre-
quency of occurrence of intensity i, ni is the number of
observations of intensity i, and nt is the total number of
intensity observations. The weighted average intensity for
the histogram envelope observed in the 10−17-M sample
was calculated according to the formula
Iavg =
P∞
a=1*10−4AUia*ni=nt . Plots were done using Ori-
gin v8.4.
3 | RESULTS AND DISCUSSION
We used SEM to examine the surface morphology of the
platforms after fabrication to confirm the presence of the
pyramid structures, prior to the addition of graphene. We
observed that the pyramids form a quasiperiodic array of
hexagonal arrangement uniformly distributed over the
surface (Figure 1a). Some variations (±30 nm) are
observed in the spacing between pyramids and the sizes
of the pyramids (±30 nm), as expected based on the fabri-
cation process.[24]
To examine the quantification characteristics of the
graphene monolayer coated gold-nanopyramid hybrid
platform, we studied the 42-amino acid form of Aβ, Aβ42,
which is thought to be a seminal pathologic agent in
Alzheimer's disease[31] and is used as a disease bio-
marker.[32] We initially applied a 20-μM solution of
freshly prepared, unaggregated, low molecular weight
Aβ[33] to our platforms. Aβ42 is known to aggregate into
oligomers and fibrils over time,[34] so to ensure that our
starting samples did not aggregate during preparation for
SERS, we prepared the samples rapidly (<10 min) at low
temperature (4C) following a stringent solubilization
and filtration procedure.[28] We acquired spectra immedi-
ately after preparation and periodically thereafter. Exami-
nation of these spectra showed that no observable
aggregation occurred within 10 min. (Figure S1).[35] In
addition, when experiments at Aβ concentrations in the
submicromolar regime are performed, rates of simple
collision-induced aggregation or nucleation-dependent
polymerization are so low that no substantial aggregation
occurs.[36] Figure 1b shows a typical SERS spectrum of
Aβ42. We also acquired Raman spectra for sodium phos-
phate buffer alone and did not observe any Raman peaks
(Figure S2). This indicated that all the peaks we observed
were from graphene or Aβ42. Several characteristic
Raman peaks were observed, including those due to Tyr
(823 and 850 cm−1), carbon–carbon (C–C) stretching (935
cm−1), Phe (982 and 1,450 cm−1), Lys or Asn (1,087
cm−1), Val or Ile (1,124 cm−1) and graphene D (1,350
FIGURE 1 Hybrid Platform and
Raman spectrum of Aβ42. (a) Scanning
electron microscopy images of the gold
pyramid structure at magnifications of
30,443 (right panel) and 161,345 (left panel).
(b) Aβ42 was prepared at a concentration of
20 μM, pH 7.4, and applied to the platform.
Abscissa indicates wavenumber (cm−1).
Peaks were assigned based on published
results.[29,30] Wavenumber assignments are
559, aliphatic; 575, C–C bond stretching
mode; 823, out-of-plane ring breathing
vibration or double Tyr (Tyr2); 850, single
bond stretching for Tyr and Val;
935, number of carbon -carbon bonds of
protein backbone or Gly; 982, C–C
stretching in β-sheets or part of Phe; 1,000,
Lys or Asn; 1,124, Val or Ile; 1,350,
graphene D peak;1,450, CH2 bending or
Phe; 1,580, graphene G peak
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cm−1), G peaks (1,580 cm−1), and D' peak (1,588
cm−1).[29,30] We note that an amide I peak (1,650 cm−1)
appears near the graphene G peak, but no overlap is
observed.
To establish the quantitative ability of the hybrid
platform, Aβ42 at concentrations ranging from 10−21 to
10−9 M was applied to the substrate, and spectra were
acquired (Figure 2a). Based on earlier reports by Wang et
al. wherein they showed that the intensity of graphene G
peak (peak height) correlated with hot spot intensity by
mapping of the graphene–gold nanopyramid hybrid sub-
strate surface, we reasoned that the graphene G peak
intensity could be used to normalize the observed protein
peak intensity.[17,37] Wang et al. showed that the intensity
of the protein peak (in that case, lysozyme) was mapped
over an area of varying hot spot intensity, and the inten-
sity of the peaks correlated linearly with that of the
graphene G peak.[17] The graphene G peak intensity
(peak height) was correlated to both the graphene config-
uration and EM field intensity.[17] To implement this, the
Aβ42 spectra were normalized to the graphene G peak
(1,580 cm−1 peak height) to account for any variation in
the local EM field intensity among the various hot spots.
This normalization allowed us to examine if the Raman
peak intensity of Aβ42 correlated with its concentration.
We normalize using the peak height at 1,580 cm−1, with-
out peak fitting, as we expect these methods to give simi-
lar results[38] particularly because the nearest peak is not
close enough to influence the peak maximum at 1,580
cm−1. Graphene was confirmed to be exclusively a single
atomic layer using the characteristics of the graphene 2D
band (data not shown) prior to transfer onto the gold
nanopyramid substrate.[37] Changes in the graphene G
peak intensity thus should arise solely from changes in
the EM field and thus can be used to normalize protein
peak intensities obtained across the substrate surface.
The graphene G peaks among spectra superimpose as a
result of the normalization. The peaks at 1,350 cm−1 did
not superimpose as did the G peaks, so we wondered if
their intensities correlated with the intensity of the pro-
tein C–C peak at 935 cm−1. We plotted the intensity of
each wavenumber for concentrations from 10−9 to 10−13
to answer this question and found that there was little
(R2 = 0.23) correlation of these values (Figure S3). The
1,350-cm−1 peak is the graphene D peak, which results
from the sp3 atoms in the carbon ring structure.[39] The D
peak is related to defects in the graphene, especially
graphene folds formed when the nearly planar graphene
is overlaid on the pyramids of the platform. As such, the
D peak is a function of surface topology and not suitable
for use as a normalization signal.[37]
We observed no qualitative differences among the
spectra obtained at different Aβ42 concentrations.
Instead, as expected, a direct relationship between peak
intensity and concentration was seen. At a single hot
spot, at which multiple analytes can bind, Raman signal
intensity is the sum of the individual intensities of all the
Raman active analytes present. Increases in signal inten-
sity with analyte concentration are thus observed until
the limited volume of the hot spot is fully occupied by
FIGURE 2 Concentration-
dependence of Raman signal
intensities. (a) Spectra of Aβ42 at
concentrations ranging from 10−13 to
10−9 M. Spectra from concentrations
of 10−15 and 10−14 were obtained but
they are not shown because they are
essentially flat in this representation.
(b) Normalized peak intensity
(AU) of the 935 cm−1 peak. All
points are the averages of three
replicates. Red bars signify standard
deviations. If error bars are not
visible, this indicates that the size of
the standard deviation was less than
the size of the data point. (c) Log–log
plot of the data from panel B. The
blue line was produced by linear
regression analysis (R2 = 0.97).
(d) Linear regression plot of the data
from panel B with R2 = 0.94
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analyte molecules, after which increases in analyte con-
centration do not lead to increased peak intensity
(Figure 3). This is seen clearly in Figure 2b, in which the
concentration dependence of peak intensity at 935 cm−1
is shown. The data produce a sigmoidal curve within
which a quasilinear region is seen extending from ~10−13
to 10−11 M (Figure 2b; between dashed lines). The linear-
ity within this region is more apparent from examination
of a log–log plot (Figure 2c), which we utilize because of
the very broad concentration regime studied. Regression
analysis of this region produces a line with a correlation
coefficient of 0.94 (Figure 2d). From the peaks emanating
from protein, the 935 cm−1 peak has the highest relative
peak intensity and the lowest signal/noise ratio. As such,
experimental noise has less impact on its intensity, and
thus, the linear relationship between intensity of the 935
cm−1 peak and concentration provides a more accurate
quantitation than the use of more isolated vibrational
modes at 1,087 and 1,124 cm−1 (Figure S4). We observed
increasing protein concentration towards the perimeter
of the applied droplet, induced by the surface tension of
the liquid during drop casting, likely due to the “coffee
ring” effect. We find that the concentration change is not
high enough to influence the linear relationship between
protein concentration and peak intensity (c.f. error bars
on Figure 2b). One explanation for the linearity of
increasing SERS intensity with increasing concentration
is that many protein molecules can fit within a single hot
spot before it is filled, which would be difficult to observe
if the hot spot size is closer to the size of a single analyte
molecule.
As analyte concentration decreases, not all hot spots
will have adsorbed analytes, and a direct relationship
between peak intensities and analyte concentration does
not exist (Figure 4). For this reason, instead of quantify-
ing signal intensities at individual hot spots, we imple-
ment a quantification method that considers instead the
frequency of hot spots from which Raman spectra signals
of the analytes are detectable. To determine this fre-
quency, we scanned relatively large areas (~50 × 50 μm)
of the hybrid platform using Raman mapping at a step
size of 1 μm (i.e., a 1-μm2 area of pixels for each
FIGURE 3 (a–c) Dependence of Raman signal intensity on analyte number concentration at hot spots. In analyte concentration
regimes in which essentially all hot spots (red clouds) contain at least one analyte molecule, Raman signal intensity depends on analyte
number concentration (a). Signal intensity thus increases with analyte concentration (b) until hot spots are saturated with analytes (c), at
which time accurate determination of concentration is no longer possible because not all analytes are associated with hot spots. (d–e) Hot
spot occupancy versus analyte concentration. As illustrated in (d), at lower concentrations, hot spot occupancy is <100%, and peak
intensities begin to correlate with the probability of an individual protein molecule being collocated with a hot spot, as opposed to the
number of molecules at each hot spot (as in the high concentration regime). In the low concentration regime, quantification is accomplished
by determination of occupancy frequency per se. Panel (e) illustrates a concentration regime in which most or all hot spots contain at least
one analyte molecule. Hot spot occupancy thus is ffi100%, and signal intensity depends on the number of analyte molecules. Analyte
molecules within a hot spot are shown in red. Analytes outside of hot spots are blue
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measurement). This scanning encompasses the entire
area of the original droplet, including the outer perimeter
and inside of the dried ring, so that we get a representa-
tive sampling of the protein concentration. We performed
this scanning on platforms on which we applied Aβ42 in
concentrations ranging from 10−18 to 10−10 M. Figure 5
(upper panels) shows heat maps of the intensity data
collected at concentrations of 10−13, 10−15, and 10−17 M.
Inspection reveals a substantial concentration-dependent
decrease in frequency. A plot of the frequency distribu-
tion (Figure 5, lower panel) shows that no signals were
observed at Aβ42 concentrations of 10−20 or 10−19 M. A
direct relationship between frequency and concentration
was observed between 10−18 to 10−15 M (Figure 5, lower
panel, solid line). Above 10−15 M, a concentration regime
is encountered in which the majority of hot spots have at
least one Aβ peptide, and increasing Aβ concentration
results in an increase in the number of peptides per pyra-
mid but not in a substantial increase in the percentage of
pyramids with at least one peptide (Table 1). Table 1
shows the frequency of observable spectra in each of the
reported concentrations, from two independent experi-
ments, which is the number of detectable signals divided
by the total number of scans across the area examined. If
analyte concentration is within the transition region
between partial and full hot spot occupancy, simple dilu-
tion will allow accurate quantification based solely on
occupancy frequency. We note that Pérez-Ruiz et al., in
studies determining tau concentrations,[40] have also suc-
cessfully employed a frequency approach (cf. Figure 5 of
this manuscript with fig. 5 of Pérez-Ruiz et al.). This
approach enabled attomolar limits of detection
depending on whether samples were prepared in buffer
(24 aM) or blood plasma (55 aM). Coupled with analogue
measurements at higher concentrations, a dynamic con-
centration range of six orders of magnitude could be
obtained. These capabilities compare favorably with our
own—a dynamic range of seven orders of magnitude and
a limit of detection of 1 aM.
It should be pointed out that the true detection limit
is when the concentration of the analyte becomes so low
that the probability of a single molecule existing within a
FIGURE 4 Determination of peptide concentration using hot spot signal frequency measurements. Upper panel: Intensity mapping of
the 935 cm−1 peak at concentrations of 10−13, 10−15, and 10−17 M. The step size of the mappings was 1 μm, and 2,600 spectra were acquired
at each concentration. Lower panel: A log–log plot of concentration (M) versus hot spot signal frequency (%) determined in the
concentration range of 10−20 to 10−10 M. For ease of visualization, points at 10−20 and 10−19 M, which had zero intensity, are plotted with
frequencies of 0.0001%. Solid line shows result of linear regression analysis in the concentration regime 10−18 to 10−15 M, inclusive
(correlation coefficient R2 = 0.97). Data were obtained from two independent experiments and are shown as averages plus the frequency
ranges (shown as black bars) produced by the two points. Where the black bars are not visible, this indicates that the range was smaller than
the diameter of the point indicating the average frequency [Colour figure can be viewed at wileyonlinelibrary.com]
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20-μL droplet is <1. This probability is 0.37 at 10−19 M.
This explains why, in practice, no Aβ signal was observed
at lower concentrations. In theory, there is a finite proba-
bility that a single molecule will exist within an applied
volume at any concentration and that a spectroscopist
can spend sufficient time to find its location and signal
on the platform.
We next sought to determine, in the frequency regime
of concentration, how intensity was related to number of
analyte molecules per hot spot. To do so, we created his-
tograms of normalized spectral intensities at the same
concentrations in Figure 5 (10−17, 10−15, and 10−13 M).
We used the intensity of the 935 cm−1 peak (C–C bonds)
for this purpose, as this peak had been used to quantify
Aβ concentration (Figure 2). Our expectation was that
the lowest observed intensity should be produced by a
single analyte molecule and that subsequent signal inten-
sities should be integer multiples of that lowest intensity.
FIGURE 5 Hot spot intensities. The
graphene normalized signal intensities of the
935 cm−1 Raman peak acquired at Aβ
concentrations of 10−17, 10−15, and 10−13 M are
presented in histograms. Axes are frequency
(ordinate) and normalized intensity (abscissa).
Numbers at blue arrows signify the number of
monomers producing the observed intensities
[Colour figure can be viewed at
wileyonlinelibrary.com]
TABLE 1 Hot spot signal frequency versus Aβ42 concentration
Concentration (log M) −20 −19 −18 −17 −16 −15 −14 −13 −12 −11 −10
Frequency (Exp. #1) (%) 0.000 0.000 0.023 0.470 4.12 38.4 72.2 84.9 95.2 100 100
Frequency (Exp. #2) (%) 0.000 0.000 0.011 0.102 3.85 28.7 59.2 87.2 96.0 100 100
Note. The frequencies of observable signals from hot spots were determined over a concentration range of 10−18 to 10−10 M in two independent experiments.
Frequency (%) = 100 × (number of hot spots with detectable signal)/(total number of hot spots).
YU ET AL. 439
In Figure 5, we observed a single node with an average
intensity of 1.3 × 10−4 AU. At a concentration of 10−15
M, this node was also observed, in addition to prominent
nodes at intensities that were double or triple that inten-
sity. This shifting of the overall frequency distribution to
higher intensities was seen at 10−13 M as well, a concen-
tration that produced nodes (blue arrows) at intensities
that were 23- to 30-fold larger than the lowest intensity
node, consistent with the conclusion that this distribu-
tion reflected hot spots containing 23–30 analyte mole-
cules. When we compared the average signal intensities
for each node envelope with those predicted based on
multiples of 1.3 × 10−4 AU per monomer, we observed
remarkable agreement (mean and standard deviation of
the differences was 0.04 ± 0.09 × 10−4 AU; Table 2).
These data support the conclusion that we are, at mini-
mum, able to differentiate signals produced by 1–30 pep-
tides per hot spot.
Raman intensities of proteins depend not only on
analyte quantity per hot spot, but on the structure of the
protein, its orientation relative to the hot spot surface,
and the EM field intensity. Our normalization procedure
controls for the latter factor. The variation in the former
two factors is reflected in the widths of the overall inten-
sity envelopes observed in the histograms. These increase
with concentration, but even at a concentration of 10−13
M, we see that the envelopes reflect a discrete range of
analyte numbers, as opposed to including intensities
from the continuum of possible analyte numbers per hot
spot. This likely reflects the fact that the application and
binding of protein to the matrix of pyramids is consistent
with simple laws of mass action.
4 | CONCLUSION
This work demonstrates the quantification ability of the
graphene–gold hybrid SERS platform using Raman
mapping. The platform exhibits a linear relation between
peak intensity and concentration at single hot spots (high
analyte concentration), as well as a linear relationship
between detection frequency and analyte concentration
when scanning multiple hot spots (low analyte concen-
tration). The platform is capable of single-molecule detec-
tion. The useful dynamic range of the hybrid platform of
seven orders of magnitude (three orders of magnitude for
higher concentration and four orders of magnitude of
lower concentration) offers the possibility that the plat-
form could be useful in a broad range of applications
such as early stage diagnosis of Alzheimer's disease.
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